April 29, 2015
Rapid Micro Biosystems Secures $25 Million in Series C Equity Financing

April 29, 2015
Stealth Foundry Grad Twelve Racks Up $35M for Percutaneous Mitral Valve Replacement

April 1, 2015
Warrant Exercises Generate $17.2 Million; Proceeds to Advance Next-Generation Compounds and Support Commercialization of Korlym.

April 1, 2015
CardioDx Announces Positive Results from Clinical Utility Study Evaluating the Corus CAD Blood Test's Influence on Clincial Decision Making in the Assessment of Obstructive Coronary Artery Disease in Women

March 24, 2015
Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock.

March 12, 2015
Allergen Research Corporation Completes $80 Million Series B Financing to Advance Drug Development Portfolio for Food Allergy

March 10, 2015
Collegium Raises $50 Million Financing to Support Commercial Development of its Lead Abuse-Deterrent Product Candidate.

March 6, 2015
Amarin Announces $52.8 Million Private Placement

March 4, 2015
Corcept Recorded Net Revenue of 9.0 Million in the Fourth Quarter of 2014, Compared to $4.1 Million for the Same Period in 2013. The Company Estimates 2015 Net Revenue Will Be Between $47 Million and $53 Million.

February 26, 2015
Collegium Pharmaceutical Announces Notice of Allowance for U.S. Patent Covering DETERx, and Abuse-Deterrent Analgesic for Chronic Pain

February 17, 2015
CoverMyMeds and Practice Fusion Partner to Bring Electronic Prior Authorizations for Medications to Over 110,000 of Practice Fusionís Users

February 15, 2015
Healthy Women and the National Association of Nurse Practitioners in Women's Health are Partnering with CardioDx on a New Patient Advocacy Campaign to Empower Women to be Proactive in Discussing Their Heart Health and Testing Options with Their Healthcare Providers. It's Called Spread the Word.

February 9, 2015
Collegium Pharmaceutical Appoints Chief Financial Officer and New Member to its Board of Directors.

January 15, 2015
ALPHAEON Corporation Closes Series A Preferred Stock Financing In A Transaction Led By Longitude Capital Management Co., LLC.

January 14, 2015
Flamel Sinks on Jazz Pharma Patent Ruling

© 2015 Longitude Capital Management Co., LLC. All rights reserved.